Related Experiment Video
Updated: Jun 22, 2026

10:28
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Imaging of peritoneal carcinomatosis
Santiago González-Moreno1, Luis González-Bayón, Gloria Ortega-Pérez
1Peritoneal Surface Oncology Program, Department of Surgical Oncology, Centro Oncológico MD Anderson International España, Calle Arturo Soria 270, Madrid 28033, Spain. sgonzalez@mdanderson.es
Cancer Journal (Sudbury, Mass.)
|June 27, 2009
Summary
Accurate detection of peritoneal carcinomatosis is challenging for imaging, impacting treatment selection. Enhanced imaging and radiologist expertise are vital for effective patient management and surgical planning.
Area of Science:
- Radiology
- Oncology
- Surgical Oncology
Background:
- Peritoneal carcinomatosis detection is challenging despite advanced imaging.
- Underestimation of disease burden can occur due to limitations in detecting small implants.
- Effective treatment relies on accurate staging and surgical planning.
Purpose of the Study:
- To review the role of imaging in evaluating peritoneal carcinomatosis.
- To highlight the importance of accurate disease assessment for treatment selection.
- To emphasize the collaboration between radiologists and surgeons.
Main Methods:
- Review of contrast-enhanced multidetector computed tomography (MDCT) as the standard.
- Discussion of magnetic resonance imaging (MRI) for complementary data.
- Evaluation of positron emission tomography (PET) for extraperitoneal involvement.
Main Results:
- MDCT is the primary imaging modality for peritoneal carcinomatosis.
- MRI provides valuable supplementary information.
- PET is mainly indicated for detecting unsuspected extraperitoneal disease in specific neoplasms.
Conclusions:
- Accurate imaging is critical for patient selection for cytoreductive surgery and intraperitoneal chemotherapy.
- Radiologist expertise and surgeon-radiologist collaboration are essential.
- Continued advancements in imaging are needed to improve detection of peritoneal surface disease.

